DALLAS (TIP): American Association of Cardiologists of Indian Origin (AACIO), at its Fall meeting December 4, honored Greg Behar, President and CEO of Boehringer lngelheim Pharmaceuticals, Inc., Dr. Joseph M. Chalil, Associate Director, Health Science Executives, Boehringer Ingelheim USA, and Dr. Dinender K. Singla, a graduate of Post Graduate Institute of Medical Education and Research, Chandigarh, India for their achievements in the field of Cardiology.
In addition, AACIO Young Investors Award was given to Dr. Ganesh Athappan and the Dr. Madhukar Deshmukh awards were given to Dr. Forum Kamdar and Dr. Manavjot Siddhu. AACIO awards the Dr. Krishna Ramaswamy and two Dr. Madhukar Deshmukh Young Investigator Awards at the AACIO dinner meetings held each year during the American College of Cardiology and the American Heart Association annual convention in March and November. The finalists presented their abstract at the meeting and each received $1000.00 award and a plaque The Fall 2013 annual event, organized by AACIO in coordination with Texas Indo- American Physicians Society (TIPS), North East Chapter and American Association of Physicians of Indian Origin was held at the Dallas Convention Center Theater Complex in Dallas, TX on November 17th, and was attended by over 200 physicians from around the nation.
Dr. Navin Nanda, the Founding President and Chairman of the AACIO Board of Directors, while lauding honorees for their contributions and achievements, said, “AACIO is proud to honor some of the stalwarts of the pharmaceutical industry like Greg Behar and Chris Kaplan as well as some of the upcoming personalities like Jo Chalil. They have made significant contributions to medical therapeutics in the area of cardiology.” Dr. Nanda is a Distinguished Professor of Medicine and Cardiovascular Disease, Senior Scientist, Minority Health and Research Center and UAB Center for Aging, and UAB Comprehensive Cardiovascular Center, University of Alabama at Birmingham, Alabama. Dr. Ravi Jahagirdar, President Elect, who had represented AAPI at the event, congratulated AACIO for its consistent good work, both in the academic and the applied fields, and reaching out successfully to American Heart Association, and working in tandem with them in many spheres.
He had special praise for the three Scholarship Awards that are given out each year to young aspiring medical students for poster sessions and in investigative sectors. “We at the national AAPI are proud of these activities,” he said. Dr. Jahagirdar, who will assume charge as the president of the national AAPI in June next year, pledged AAPI’s continued support in the future. In his inaugural address, Dr. Kul Aggarwal, president of AACIO, and Professor of Clinical Medicine, University of Missouri and Chief, Cardiology Section, Harry S. Truman Veterans Hospital, Columbia, Missouri, stated that AACIO provides a central forum for physicians and scientists of Indian origin, living in the United States, who have interest in Cardiovascular Medicine. “Indian Cardiologists are playing an increasingly important role in the provision of Cardiovascular services and also as academic thought leaders in the United States. We are proud of our colleagues.
AACIO is your organization and joining it adds strength to all of us,” he said. The American Association of Cardiologists of Indian Origin (aacio.org) was formed in 1986 and after crossing puberty, the organization has reached the excited stage of youth after nineteen years. A Symposium, which was part of the meeting was organized by Drs. Navin C. Nanda and Kul Aggarwal. In his insightful presentation on “Newer anticoagulants in the management of a trial fibrillation and stroke prevention” Dr. Sanjeev Saksena, Clinical Professor of Medicine, Rutgers-RWJ Medical School Medical Director, Piscataway, New Jersey, Electrophysiology Research Foundation, Warren, New Jersey & Editor-in- Chief, Journal of Interventional Cardiac Electrophysiology, provided an overview of modern trends. Dr. Amit Khera, Associate Professor, Director, Preventive Cardiology Program, Program Director, Cardiology Fellowship and Dallas Heart Ball Chair in Hypertension and Heart Disease, UT Southwestern Medical Center, Dallas Texas, addressed the audience on “Emerging therapies in dyslipidemia management, beyond statins.” Dr. Nanda educated the audience on “Choice of anti-platelet therapy in acute coronary syndromes.”
With more than 15 years in the pharmaceutical industry, Greg’s experience includes leadership roles in marketing, sales, business operations and general management. Greg joined Boehringer lngelheim in 2009 as Corporate Vice President of the Cardiovascular and Metabolic Franchise. That same year he became Vice President, Corporate Division Prescription Medicine, leading 14 countries including Northern Europe, Canada and Australia. Prior to Boehringer lngelheim, Greg worked at Novartis Pharma AG in roles of increasing responsibility in Spain and at global headquarters in Switzerland. Another honoree, Dr. Singla has received numerous honors and awards, and has been invited to give talks throughout the world. He also served as a chair/co-chair for scientific meetings, and well published in various peer reviewed journals. He is funded by the National Institute of Health and the American Heart Association grant awards since 2004.
He has served as an editorial board member for different journals, and is the current Academic Editor for Plos one and Associate Editor for Canadian Journal of Physiology and Pharmacology. Srinivas Reddy Gunukula serves on the Board of Directors of The Heart Hospital Baylor Plano and Director of Center for Advanced Cardiovascular Care at the Heart Hospital McKinnney Campus. He is well known among the Cardiology community in Dallas. Dr. Joseph M. Chalil is a Fellow of American College of Healthcare Executives and is Board Certified in Healthcare Management. He serves as Co-Chair, AAPI Industry Physician Committee and Scientific Advisor, AAPI Cardiovascular, Diabetes and Stroke Network. Dr. Chalil holds three US Patents involving usage of sensors inside Human Body in addition to other applications. His research background includes Clinical Trial Management in Cystic Fibrosis, Multiple Myeloma, and publications in American Journal of Respiratory and Critical Care Medicine. The Asian American Business Development Center, NY has awarded Dr. Chalil the 2013 Outstanding 50 Asian Americans in Business Award. He is a Visiting Professor at various Universities and serves on various company Boards. He is an expert in US Healthcare policy and a strong advocate for patient centered care.